Longitudinal Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Progression Marker

BACKGROUND: Development of reliable and accurate imaging biomarkers of dopaminergic cell neurodegeneration is necessary to facilitate therapeutic drug trials in Parkinson's disease (PD). Neuromelanin‐sensitive MRI techniques have been effective in detecting neurodegeneration in the substantia n...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaurav, Rahul, Yahia‐Cherif, Lydia, Pyatigorskaya, Nadya, Mangone, Graziella, Biondetti, Emma, Valabrègue, Romain, Ewenczyk, Claire, Hutchison, R. Matthew, Cedarbaum, Jesse M., Corvol, Jean‐Christophe, Vidailhet, Marie, Lehéricy, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Regular Issue Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359265/
https://www.ncbi.nlm.nih.gov/pubmed/33751655
http://dx.doi.org/10.1002/mds.28531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359265/
https://www.ncbi.nlm.nih.gov/pubmed/33751655
http://dx.doi.org/10.1002/mds.28531

Ejemplares similares